Stock IOLCP IOL CHEMICALS AND PHARMACEUTICALS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company IOL Chemicals and Pharmaceuticals Limited

Equities

IOLCP

INE485C01011

Pharmaceuticals

Delayed Bombay S.E.
Other stock markets
 03:53:38 2024-04-30 EDT 		5-day change 1st Jan Change
397 INR +0.18% Intraday chart for IOL Chemicals and Pharmaceuticals Limited +0.32% -14.30%
03-19 IOL Chemicals Gets Zero Observations from Brazilian Health Regulatory Agency After Inspection of Units MT
02-19 IOL Chemicals Gets Nod to Export Diabetes Drug to China MT

Business Summary

IOL Chemicals and Pharmaceuticals Limited is engaged in manufacturing and selling of pharmaceutical and chemical products. The Company operates through two segments: Chemical, and Pharmaceutical. The Chemical segment produces and sells Ethyl Acetate, Iso Butyl Benzene, Acetyl Chloride, Mono Chloro Acetic Acid, Para Amino Phenol (PAP), and others. The Pharmaceutical segment produces and sells various active pharma ingredients (API) include Ibuprofen, Metformin, Fenofibrate, Lamotrigine, Clopidogrel Bisulphate, Pantoprazole, Gabapentin, Paracetamol, and others. Its API product portfolio includes Ibuprofen, Metformin HCL, Pantoprazole Sodium, Clopidogrel Bisulphate (Form II), Lamotrigine, Losartan Potassium, Levetiracetam, Paracetamol, Fenofibrate (Micronised), and Gabapentin. Its Specialty Chemical division includes Ethyl Acetate, and Acetic Anhydride. Its Ethyl Acetate is used in industries like flexible packaging, pharmaceuticals, ink, food processing, pesticides, and paint industry.

Number of employees: 2,569

Sales per Business

INR in Million2022Weight2023Weight Delta
Pharmaceutical
56.8 %
10,027 45.9 % 12,585 56.8 % +25.52%
Chemical
43.0 %
11,749 53.8 % 9,537 43.0 % -18.82%
Unallocated
0.2 %
65 0.3 % 49 0.2 % -24.96%

Sales per region

INR in Million2022Weight2023Weight Delta
India
71.4 %
16,381 75.0 % 15,835 71.4 % -3.33%
Rest of the World
28.6 %
5,459 25.0 % 6,336 28.6 % +16.07%

Managers

Managers TitleAgeSince
Vikas Vij CEO
 Chief Executive Officer - 23-04-02
Pardeep Khanna DFI
 Director of Finance/CFO - -
Abhay Raj Singh CMP
 Compliance Officer - 19-11-13
Varinder Gupta BRD
 Director/Board Member 61 07-08-31
Vikas Gupta PRN
 Corporate Officer/Principal 32 15-05-28

Members of the board

Members of the board TitleAgeSince
Rajender Mohan Malla CHM
 Chairman 70 19-02-05
Varinder Gupta BRD
 Director/Board Member 61 07-08-31
Sandhya Mehta BRD
 Director/Board Member - 14-08-21
Vikas Gupta PRN
 Corporate Officer/Principal 32 15-05-28
Harpal Singh BRD
 Director/Board Member 68 19-02-05
Kushal Kumar Rana BRD
 Director/Board Member 54 21-06-03
Sharad Tyagi BRD
 Director/Board Member - 22-05-29
Abhiraj Gupta BRD
 Director/Board Member - -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 58,705,502 22,160,027 ( 37.75 %) 0 37.75 %

Shareholders

NameEquities%Valuation
Mayadevi Polycot Ltd.
21.54 %
12,647,402 21.54 % 55 M ₹
NCVI Enterprises Ltd.
15.96 %
9,370,139 15.96 % 41 M ₹
NM Merchantiles Ltd.
8.646 %
5,075,571 8.646 % 22 M ₹
Vasudeva Commercials Ltd.
7.945 %
4,663,859 7.945 % 20 M ₹
NCG Enterprises Ltd.
5.595 %
3,284,393 5.595 % 14 M ₹
Bhudeva Lifesciences Ltd.
4.895 %
2,873,714 4.895 % 12 M ₹
Enorg Ltd.
4.433 %
2,602,539 4.433 % 11 M ₹
Varinder Gupta
2.037 %
1,195,865 2.037 % 5 M ₹
G CONSULTANTS & FABRICATORS LTD
1.685 %
989,000 1.685 % 4 M ₹
True Value Traders Ltd.
0.6814 %
400,000 0.6814 % 2 M ₹

Company contact information

IOL Chemicals & Pharmaceuticals Ltd.

85, Industrial Area-A

141003, Ludhiana

+91 16 1222 5531

http://www.iolcp.com
address IOL Chemicals and Pharmaceuticals Limited(IOLCP)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for IOL Chemicals and Pharmaceuticals Limited

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
396.3 INR
Average target price
517 INR
Spread / Average Target
+30.46%
Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
IOL CHEMICALS AND PHARMACEUTICALS LIMITED Stock IOL Chemicals and Pharmaceuticals Limited
-14.30% 279M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+26.47% 664B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+25.64% 567B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.33% 354B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.35% 330B
ABBVIE INC. Stock AbbVie Inc.
+4.23% 286B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.51% 234B
NOVARTIS AG Stock Novartis AG
+4.77% 199B
ROCHE HOLDING AG Stock Roche Holding AG
-10.18% 196B
AMGEN INC. Stock Amgen Inc.
-4.04% 148B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. IOLCP Stock
  4. Company IOL Chemicals and Pharmaceuticals Limited